References
- 1. Aschhoff B.: Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors. Drugs Exp Clin Res 2000, 26, 249-252.
- 2. Bangert C.A., Costner M.I.: Methotrexate in dermatology. Dermatol Ther 2007, 20, 216-228.
- 3. Blower P., de Wit R., Goodin S., Aapro M.: Drug - drug interactions on oncology: Why are they important and can they be minimized? Crit Rev Oncol Hematol 2005, 55, 117-142.
- 4. Chatham W.W., Morgan S.L., Alarcón G.S.: Renal failure: a risk factor for methotrexate toxicity. Arthritis Rheum 2000, 43, 1185-1186.
- 5. Decker S., Winkelmann W., Nies B., van Valen F.: Cytotoxic effect of methotrexate and its solvent on osteosarcoma cells in vitro. J Bone Joint Surg 1999, 81-B, 545-551.
- 6. Genestier L., Paillot R., Fournel S., Ferraro C., Miossec P., Revillard J.P.: Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest 1998, 102, 247-257.
- 7. Green M.R., Chamberlain M.C.: Renal dysfunction during and after high-dose methotrexate. Cancer Chemother Pharmacol 2009, 63, 599-604.
- 8. Habermehl D., Kammerer B., Handrick R., Eldh T., Gruber C., Cordes N., Daniel P.T., Plasswilm L., Bamberg M., Belka C., Jendrossek V.: Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. BMC Cancer 2006, 6, 14-36.
- 9. Hattangadi D.K., DeMasters G.A., Walker T.D., Jones K.R., Di X., Newsham I.F., Gewirtz D.A.: Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell. Biochem Pharmacol 2004, 68, 1699-1708.
- 10. Hohenwarter O.: Selective inhibition of in vitro cell growth by the anti-tumor drug Ukrain. Drugs Exp Clin Res 1992, 18, 1-4.
- 11. Jagiełło-Wojtowicz E., Kleinrok Z., Urbanska E.M.: Ukrain (NSC631570) in experimental and clinical studies: a review. Drugs Exp Clin Res 1998, 24, 213-219.
- 12. Kang M.H., Harutyunyan N., Hall C.P., Papa R.A., Lock R.B.: Methotrexate and aminopterin exhibit similar invitro and in vivo preclinical activity against acute lymphoblastic leukaemia and lymphoma. Br J Haematol 2009, 145, 389-393.
- 13. Kimura E., Nishimura K., Sakata K., Opa S., Kashiwagi K., Igarashi K.: Methotrexate differentially affects growth of suspension and adherent cells. Int J Biochem Cell Biol 2004, 36, 814-825.
- 14. Lanvers-Kaminsky C., Nolting D.M., Köster J., Schröder A., Sandkötter A., Boos J.: In vitro toxicity of Ukrain against human Ewing tumor cell lines. Anticancer Drugs 2006, 17, 1025-1030.
- 15. Liepins A., Nowicky J.W., Bustamante J.O., Lam E.: Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-631570). Drugs Exp Clin Res 1996, 22, 73-79.
- 16. Lohninger A., Hamler F.: Chelidonium majus L. (Ukrain) in the treatment of cancer patients. Drugs Exp Clin Res Drugs 1992, 18, 73-77.
- 17. Nowicky J.W., Hiesmayr W., Liepins A.: Influence of Ukrain on DNA, RNA and protein synthesis in malignant cells. Drugs Exp Clin Res 1996, 22, 81-91.
- 18. Nowicky J.W., Manolakis G., Meijer D., Vatanasapt V., Brzosko W.T.: Ukrain both as an anticancer and immunoregulatory agent. Drugs Exp Clin Res 1992, 18, 51-54.
- 19. Nowicky J.W., Nowicky W., Liepins A.: Cytostatic and cytotoxic effects of Ukrain on malignant cells. J Chemother 1993, 5, 797-780.
- 20. Panzer A., Hamel E., Joubert A.M., Bianchi P.C., Seegers J.C.: UkrainTM a semisynthetic Chelidoniummajus alkaloid derivative, acts by inhibition of tubulin polymerization in normal and malignant cell lines. Cancer Lett 2000, 160, 149-157.
- 21. Roublevskaia I.N., Haake A.R., Ludlow J.W., Polevoda B.V.: Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain. Drugs Exp Clin Res 2000, 26, 141-147.
- 22. Strang A., Pullar T.: Methotrexate toxicity induced by acute renal failure. J R Soc Med 2004, 97, 536-537.
- 23. Świerkot J., Szechiński J.: Methotrexate in rheumatoid arthritis. Pharmacol Rep 2006, 58, 473-492.
- 24. Tian H., Cronstein B.N.: Understanding the mechanisms of action of methotrexate. Bull NYU Hosp Jt Dis 2007, 65, 168-173.
- 25. Twentyman P.R., Luscombe M.: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 1987, 56, 279-285.
- 26. Uglyanitsa K.N., Nefyodov L.I., Doroshenko Y.M., Nowicky J.W., Volchek L.V., Brzosko W.J., Hodysh Y.J.: Ukrain: A novel antitumor drug. Drugs Exp Clin Res 2000, 26, 341-356.